Molecular hydrogen is produced as a fermentation by-product in the large intestine of animals and its production can be correlated with the digestibility of the carbohydrates consumed. Pathogenic Helicobacter species (Helicobacter pylori and H. hepaticus) have the ability to use H 2 through a respiratory hydrogenase, and it was demonstrated that the gas is present in the tissues colonized by these pathogens (the stomach and the liver respectively of live animals). Mutant strains of H. pylori unable to use H 2 are deficient in colonizing mice compared with the parent strain. On the basis of available annotated gene sequence information, the enteric pathogen Salmonella, like other enteric bacteria, contains three putative membrane-associated H 2 -using hydrogenase enzymes. From the analysis of gene-targeted mutants it is concluded that each of the three membrane-bound hydrogenases of Salmonella enterica serovar Typhimurium are coupled with an H 2 -oxidizing respiratory pathway. From microelectrode probe measurements on live mice, H 2 could be detected at approx. 50 µM levels within the tissues (liver and spleen), which are colonized by Salmonella. The halfsaturation affinity of whole cells of these pathogens for H 2 is much less than this, so it is expected that the (H 2 -utilizing) hydrogenase enzymes be saturated with the reducing substrate in vivo. All three enteric NiFe hydrogenase enzymes contribute to virulence of the bacterium in a typhoid fever-mouse model, and the combined removal of all three hydrogenases resulted in a strain that is avirulent and (in contrast with the parent strain) one that is not able to pass the intestinal tract to invade liver or spleen tissue. It is proposed that H 2 utilization and specifically its oxidation, coupled with a respiratory pathway, is required for energy production to permit growth and maintain efficient virulence of a number of pathogenic bacteria during infection of animals. These would be expected to include the Campylobacter jejuni, a bacterium closely related to Helicobacter, as well as many enteric bacteria (Escherichia coli, Shigella and Yersinia species).
Hydrogen oxidation
The energy trapped within hydrogen gas has been used by prokaryotes as a source of reductant for nearly a billion years [1, 2] . The hydrogenases of interest in gleaning energy from the gas are the NiFe 'uptake' types, also ancient enzymes. On binding and then 'splitting' of the gas by membraneassociated nickel-containing hydrogenases, the energy contained in the low-potential electrons is conserved by a combination of transmembrane potential and proton gradient coupling mechanisms [3] . This process is facilitated by a series of quinone-binding proteins or (haem-containing) electron carriers, provided a terminal acceptor (preferably O 2 ) is available. The vast majority of previous studies in the area of bacterial H 2 metabolism view the subject from the perspective of its occurrence in soil or water-borne organisms in nature. However, the recent observations that some pathogenic bacteria use molecular hydrogen within animal hosts to either colonize the specific diseased tissue [4] or to cause disease [5] now expands the subject of respiratory hydrogen activation and oxidation to the field of infectious diseases, the subject herein.
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Production of hydrogen within animals
Carbohydrates that are incompletely absorbed by the small intestine within animals reach the colon where they are fermented by intestinal bacteria [6, 7] . These floras are primarily anaerobes present in animal faeces or in the colon and perform H 2 producing reactions associated with short chain volatile fatty acid production. Along with these fatty acids the gases H 2 and CO 2 are produced. These gases associated with fermentations are not utilized by the host, but are primarily either lost in faeces or flatus, or assimilated by methaneproducing bacteria [7, 8] . Some studies indicate that a significant proportion of the H 2 produced by the colonic flora is absorbed into the bloodstream and can even be detected on the breath [9, 10] . For example, an estimated 14% [9] or 20% [7] of the total colonic H 2 production was reported to be carried through the human bloodstream and then released into the lungs.
Helicobacter species and hydrogenase
Helicobacter pylori is a pathogen, which solely colonizes the mucosal surfaces of the human stomach, where it gives rise to gastritis, peptic ulcers and is correlated with the development of certain types of gastric cancer [11] . It is the persistent nature of the bacterium combined with the highly inflammatory response of the host that are associated with the most severe manifestations of disease [12] . H. hepaticus is an enterohepatic type of Helicobacter that is receiving research attention due to its association with liver disease (including liver tumours) in mice [13] and perhaps in primates [14] . Reduction of the H. pylori membrane fraction (the fraction containing the bulk of the hydrogenase activity) by H 2 resulted in the membrane-associated cytochromes acquiring a reduced state, indicating that an energy-conserving respiratory chain is operating with the electrons generated from H 2 [15] . Coupling of H 2 oxidation with reduction of a variety of positive redox potential acceptors, like other uptake type hydrogenases, was a characteristic of both studied Helicobacter species hydrogenases. The Helicobacter enzymes are subject to reductive activation by H 2 while in the membrane, in which highest enzyme activities were observed when the enzyme is reduced [16] .
Hydrogen availability and its use in tissues colonized by Helicobacter
Although H 2 had been directly measured in intestinal tracts of terrestrial arthropods, H 2 levels in tissues of vertebrate animal hosts had not been assessed until the substrate was postulated to be important in H. pylori infection. Both the mucous lining of the (mouse) stomach [4] as well as the lobes of the liver [16] contained ample amounts of molecular H 2 . The average hydrogen content of the mucus layer of the mouse stomach was determined to be 43 µM (range of 17-93 µM); this is more than 20-fold the whole cell half saturation affinity of H. pylori for hydrogen. Similarly, the H 2 levels in liver tissue were approx. 20-fold higher than the H. hepaticus affinity for H 2 . These H 2 levels are most probably achieved by a combination of cross-epithelial diffusion of the gas from the bowel, and from H 2 carried in the bloodstream [4, 6] . The properties of Helicobacter hydrogenases in terms of affinity for the substrate (see Table 1 ) make them useful enzymes for binding H 2 , especially when considering the (relatively high) H 2 levels measured within the tissues that are colonized (see Table 1 ).
Only approx. 20% of mice inoculated with an H 2 oxidation negative mutant strain of H. pylori contained any detectable Helicobacter in their stomach, whereas the parent strain colonized every inoculated mouse [4] . Moreover, for those scored as colonization positive by the mutant, the colonization numbers (colony forming units per stomach) were clearly less than that for the parent strain. These results indicate that H 2 is a major, although not the sole, utilizable energy substrate for H. pylori in the host.
Other hydrogen-utilizing pathogens
That hydrogen present in animals (as a consequence of metabolism by the normal colonic flora) is an energy yielding substrate for maintenance of a pathogenic bacterium may be extended to a number of (mostly enteric) pathogens. On the basis of publicly available genome sequence data, a number of human pathogens have genes encoding all the components required for gleaning energy from H 2 respiration [6] . Having the genes for hydrogenase alone and its regulation are not sufficient to conclude H 2 utilizing ability. The genes that are necessary include the structural genes for the membranebound hydrogenase and for shuttling of those electrons to quinone-or haem b-binding proteins, as well as the accessory proteins for the NiFe hydrogenase enzymes' maturation. Bacterial genomes of pathogens that satisfy these criteria include Salmonella enterica serovars Typhi and Typhimurium, Escherichia coli 0157, Shigella ( flexneri and sonnei) and Campylobacter jejuni. The above bacteria also contain the complete respiratory electron transport chain (normally used in common by H 2 and other low potential electrons donors), including more than one O 2 -binding terminal oxidase. The extent to which these bacteria use molecular hydrogen is not known, but they exist (colonize the host) closer to the original source of H 2 (the fermentative colonic bacteria) than either H. pylori or H. hepaticus. Molecular hydrogen levels measured in tissues colonized by H 2 oxidizing pathogens (and the measured whole cell half-saturation H 2 affinity of the pathogen) are shown in Table 1. H 2 use by S. typhimurium. It was suggested that H 2 -using hydrogenase enzymes might enable enteric bacteria to glean energy from the splitting of molecular hydrogen [17] . The possible importance of H 2 use to the pathogenicity of S. typhimurium, a common food poisoning bacterium closely related to the typhoid fever-causing bacterium S. typhi, was recently assessed [5] . Mutant strains of S. typhimurium in each of the three putative membrane-bound NiFe hydrogenases were made. The mutations were demonstrated to be nonpolar (i.e. did not affect transcription of downstream genes) by reverse transcriptase-PCR approaches. Also, it was shown that the predicted enzymes were functional in a respiratory (H 2 -oxidizing) fashion. Mutation of each individual gene decreased the H 2 oxidation activity of the strain compared with the wild-type, and all double mutant strains (each containing only one of the three hydrogenases) exhibited activities well above the background strain (the strain containing no uptake hydrogenases) [5] . All of the hydrogenase activities could be coupled with the most energetically favourable of all terminal substrates, namely oxygen.
To assess critically the possible role of Salmonella hydrogen oxidation in virulence, the various mutant strains, and especially the triple mutant strain lacking all H 2 oxidation activity, were tested for their capacity to cause typhoid fever in mice [5] . Out of 30 wild-type-inoculated mice, 29 were dead on day 10 post-inoculation, whereas all 30 triple mutant-inoculated mice survived (experiment was terminated after day 40). Importantly, a partially complemented triple mutant strain (in which one of the uptake hydrogenases was reintroduced on a plasmid) was capable of oxidizing H 2 and virulence capacity was restored; thus the phenotype of the triple mutant cannot be due to some spurious unknown mutation. The animal results (i.e. virulence tests; see Table 1) demonstrate the importance of H 2 use by an enteric bacterium for growth within an animal.
Perspective
Most virulence characteristics of pathogens are assigned roles as secreted toxins or inflammation-eliciting determinants [18] or in specialized cases, enzymes that modify the colonization environment to make it permissive for the pathogen. However, the primary sources of energy used by infectious bacteria to sustain their growth, once they are established in an animal host, remain largely unknown [18] . As molecular H 2 is an energy substrate not used by the host, the bacterium has an abundant and continuous supply of high-energy substrates. The only competitors for this substrate are commensal flora; however, for H. pylori (which colonizes the unique and acidic gastric environment) this is probably of little consequence. The enteric pathogenic bacteria must of course compete with many (non-pathogenic) bacteria within the intestinal tract. Perhaps this competition is the reason that enterics like Salmonella and E. coli contain multiple H 2 -oxidizing hydrogenases (that presumably function in different host environments). Demonstration of H 2 use to H. pylori colonization and to Salmonella virulence capacity represent new aspects towards our understanding of host-pathogen relationships. Molecular hydrogen use was not formerly recognized as a factor in human-pathogen relationships.
If pathogens rely on hydrogen produced by the colonic flora, is it possible diet alterations (and thus H 2 production) could be an approach to rid an individual of (H 2 utilizing) pathogens? Considering the high affinities of H 2 -oxidizing hydrogenases for their substrate, H 2 levels would have to be decreased within the host individual to sub-µM levels, and our data (albeit for mice) indicates that levels in tissues are in the 40-60 µM range. Therefore reducing or eliminating H 2 producing flora is an impractical approach (and probably unwise as such bacteria undoubtedly have beneficial attributes for proper digestion). A better approach may be to design inhibitors of the H 2 -utilizing hydrogenases. As the (H 2 -utilizing) enzymes contain a highly unique active centre containing Ni and Fe with attached CN and CO ligands [19] , we should expect few host affects by use of active sitespecific inhibitors. Another approach could be to starve the pathogen of nickel, an essential element for the uptake-type hydrogenases.
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